EODData

MEMBERSHIP REGISTER LOG IN

NYSE, ABBV: Abbvie Inc

10 Apr 26 15:59
LAST:

208.0

CHANGE:
 4.46		OPEN:
213.0		HIGH:
214.1		ASK:
69.7		VOLUME:
1.86M
CHG(%):
2.10		PREV:
212.4		LOW:
207.8		BID:
68.7		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Apr 26213.6214.1207.8207.94.63M
09 Apr 26209.5213.5208.7212.44.48M
08 Apr 26206.3212.2204.6211.65.48M
07 Apr 26206.2206.5201.7206.48.8M
06 Apr 26207.0209.0205.3206.74.93M
02 Apr 26214.0214.6207.7208.85.15M
01 Apr 26218.4220.5213.8215.05.7M
31 Mar 26215.1219.2214.9217.58.31M
30 Mar 26212.3213.9210.8213.17.49M
27 Mar 26211.4213.5209.1209.45.65M

PROFILE

Name:Abbvie Inc
About:AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Sector:Healthcare
Address:1 North Waukegan Road, North Chicago, IL, United States, 60064-6400
Website:https://www.abbvie.com
CUSIP:00287Y109
CIK:0001551152
ISIN:US00287Y1091
FIGI:BBG0025Y4RY4
LEI:FR5LCKFTG8054YNNRU85

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:87.58 
Forward P/E:12.83 
PEG Ratio:-1.99 
Price to Sales:6.81 
Price to Book:-111.72 
Profit Margin:0.04 
Operating Margin:0.36 
Return on Assets:0.10 
Return on Equity:1.38 
EPS Ratio:2.36 
DivYield:0.03 
Div/Share:6.47 
Revenue:59.644B 
EBITDA:18.186B 
Shares:1.769B 
Market Cap:367.973B 

TECHNICAL INDICATORS

MA5:209.000.5%
MA10:210.881.4%
MA20:210.891.4%
MA50:220.496.0%
MA100:222.997.2%
MA200:216.764.2%
STO9:11.15 
STO14:19.39 
RSI14:53.80
WPR14:-76.04
MTM14:3.01
ROC14:0.01 
ATR:5.44 
Week High:214.102.9%
Week Low:201.663.2%
Month High:231.2711.2%
Month Low:201.664.2%
Year High:244.8117.7%
Year Low:164.9726.1%
Volatility:6.72 

RECENT DIVIDENDS

Date Amount
16 Jan 2026$1.73
15 Oct 2025$1.64
15 Jul 2025$1.64
15 Apr 2025$1.64
15 Jan 2025$1.64
15 Oct 2024$1.55
15 Jul 2024$1.55
12 Apr 2024$1.55
12 Jan 2024$1.55
12 Oct 2023$1.48